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Abstract 
Background: Depression is one of the most common mental health disorders addressed in 
primary care with a lifetime prevalence of 12.2%. Current depression screening rates are low, 
with only 2.0% of primary care visits having depression screening suggesting that the vast 
majority of older adult patients suffering from depression do not receive adequate treatment. 
Methods: The goal of this quality improvement project was to increase depression screening 
rates in an outpatient primary care setting in Upstate New York. This was accomplished by 
implementing the PHQ-2 screening tool for depression screening in adults over the age of 65. 
The goal was for providers to screen at least 30 to 40 patients within a three-month period. 
Results: At the end of the 12-week time period, a total of 212 patients were screened for 
depression. Providers were interviewed on their use of the tool, and the number of patients 
screened, treated or referred, were reported. Nineteen patients were referred to a mental health 
provider or prescribed an antidepressant. Twenty seven were referred for counseling, and sixty 
four were given a follow-up appointment for further evaluation. The theoretical framework was 
used to optimize primary care, and assist the primary care clinic, in merging towards an 
integrated behavioral health care model. Conclusion: Screening for depression in primary care, 
helps to increase access to quality health care and services. Implementing the project led to the 
integration of a depression screening program that will be used in the medical clinic to improve 
the outcomes of patients with depression. Increasing the number of patients screened for 
depression, will decrease the incidence of suicide among older adults, and help ensure all older 
adults who are at risk are identified and offered treatment. 
 
Keywords: depression, depression screening, primary health care, mental health, quality 
indicators, quality of health care, older adults.  
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Introduction 
An estimated eighty percent of older adults with depression receive their treatment in 
primary care settings; while 10% of these older adults have significant clinical depression (Park 
& Unὓtzer, 2011). Depression is highly prevalent in the general population, and is associated 
with significant suffering and disability (O’Connor et al., 2009; Santos, Huang, Menezes, & 
Scazufca, 2016). At 12.2% lifetime prevalence, depression is one of the most common mental 
health disorders addressed in primary care (Duhoux et al., 2012). Depression is also a chronic 
condition that is substantially under diagnosed and undertreated in primary care settings (Saver 
et al., 2007). 
Furthermore, despite the availability of effective treatments, such as antidepressant 
medications and psychotherapies, the routine care that is often received by depressed patients is 
wholly inadequate and ineffective (Saver et al., 2007; Schoenbaum et al., 2002). Yet the 
numerous studies that have highlighted a gap in the treatment of depression, evidence-based 
practices for depression have not been fully implemented in primary care settings (Duhoux et al., 
2012; Post et al., 2009). Moreover, efforts to increase primary care provider’s (PCP) knowledge 
of appropriate depression treatments, and to provide proper tools for identifying patients with 
depression, have resulted in minimal impact on outcomes (Post et al., 2009).  
Background 
 Currently, there is substantial evidence to support that primary care providers fail to 
identify 30-50% of older adults with depression (Agency for Healthcare and Quality, 2013); thus 
older primary-care patients tend to report far more disability associated with depression than 
community-dwelling older adults (Yates et al., 2004; Arean & Ayalon, 2005). Since most of 
these primary care providers lack adequate training to adequately assess depression, or have 
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insufficient time to assess mental health issues, or are uncomfortable working with depressed 
older adults (Gray & Dihingo, 2015; Arean & Ayalon, 2005). Primary care presents a key 
opportunity for identifying older adults with depression (Park, 2011). Thus, the implementation 
of systematic screening has often been advocated by depression experts as a means of improving 
detection, treatment, and outcomes of depression (Agency for Healthcare and Quality, 2013).  
The American Geriatrics Society recommends using the patient health questionnaire-2 
(PHQ-2), as a screening tool to aid in the identification of depression in older adults (Maurer & 
Darnall, 2012). It has been further postulated that approximately 10-15% of older adults seen in 
primary care settings, do not present or fit the typical picture of a depressed adult; thus it is 
expected that at least 5% of the patient population, via the use of the PHQ-2 screening tool, 
would screen positive for depression (Sanchez, Eghaneyan, & Trivedi, 2016).  
Given that the current depression screening rates are astoundingly low, and knowing that 
only about 2.0% of primary care visits document that actual depression screening was 
performed. The increase in identification via the implementation of a screening program would 
most likely increase depression screening rates significantly. Also the current prevalence rates 
ranging anywhere from 20% to 55%, suggests that the vast majority of older adult patients 
suffering from depression do not receive adequate treatment (Duhoux et al., 2012). Moreover, 
the quality indicators that account for patient education about depression screening reveal large 
disparities ranging from 20% to 90% (Duhoux et al., 2012). 
Furthermore, despite the numerous studies that have highlighted an important gap in the 
treatment and management of depression (Santos et al, 2016; Duhoux et al, 2012), the primary 
care setting presents an important opportunity for the detection and treatment of geriatric 
depression (Park & Unὓtzer, 2011). Given the fact that most primary care providers fail to 
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identify older adult patients as being depressed; implementation of a systematic screening 
program may be of use in improving positive outcomes in depressed older adult patients 
(O’Connor et al., 2009). Hence, depression screening is predicated on the notion that early 
depression identification will allow timely and effective treatments to be delivered, and that the 
benefits of such treatment will outweigh any subtle risks or harm (O’Connor et al., 2009).  
Additionally, the analysis of the project site will look at the three key areas; (1) measure 
the gaps against benchmarks, used by the Agency for Health Care Research and Quality (AHRQ) 
through the use of a quality tool that provides a systematic method of comparing current 
practices with industry best practices; (2) determining the barriers to instituting industry best 
practices; and (3) the feasibility of implementing best practices by the target organization 
(AHRQ, 2017). This analysis will lead to the determination of what gaps exist between those in 
need of depression screening, and those receiving the actual care/treatment in the primary care 
clinic (Duhoux et al., 2012). To determine the primary care capacity gap, a service gap analysis 
for the primary care clinic will be developed and will conclude with recommendations for those 
identified gaps between national recommendations and widespread clinical practice.  
Problem Statement 
The risk of depression among the elderly is indicated by increased morbidity and 
mortality, and results from lack of evidence-based care in the primary care setting. The 
implementation of evidence-based intervention for depression, which would include routine 
screening, is recommended (Shoenbaum et al., 2002; Ell, 2006; Saver et al., 2007). The lack of 
depression screening, and the high rates of depression among older adults, are associated with 
poor health outcomes, and often have serious consequences for the patient, the patient’s family, 
and the community at large (Weise 2011; Maurer & Darnall, 2012). Furthermore, depression 
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presents a significant public health problem, with the rates of geriatric depression ranging from 
5-10% (Arean & Ayalon, 2005). This failure to adequately screen, or the absence of effective 
evidence-based screening tools, has led to devastating consequences. These consequences 
include geriatric patients committing suicide, within months of contact with a primary-care 
provider (Arean & Ayalon, 2005; Raue, Ghesquiere & Bruce, 2014); thus indicating that 
depression is routinely under-diagnosed, often misunderstood, and undertreated, within the 
primary care settings (Bruce et al., 2005; Dearman et al., 2007; Arean & Ayalon, 2005).  
Review of the Literature 
A comprehensive systematic search using PubMed, CINAHL, Nursing Ovid, Psychinfo, 
Academic Search Premier, Medline and Google Scholar database was conducted using a 
combination of keywords such as: depression in primary care, quality indicators for depression 
in primary care, treatment of depression in primary care, quality care for major depression, and 
adequacy of depression treatment. Once the articles had been identified, an appraisal was done to 
determine which articles were relevant, and applicable to the literature review. A total of 40 
articles were obtained from the Google Scholar database, and a total of ten articles from 
PubMed. For these articles to be incorporated into the project, they had to have been published in 
scientific peer-reviewed journals between 2002 and 2016, and they were full-text research 
articles published in English. Exclusion criteria included research publications, editorial and 
opinion pieces conducted outside of the United States and Canada. 
Lack of Screening in Primary Care. 
Duhoux and colleagues (2012) conducted a multilevel analysis study using a sample of 
915 adults. The objective of this study was to estimate the proportion of primary care patients 
who meet the DSM-IV criteria for major depressive episode; and had received adequate 
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treatment as assessed by indicators derived from clinical practice guidelines (Duhoux et al., 
2012). The second objective was to examine individual and organizational characteristics 
associated with the receipt of at least one minimally adequate treatment for depression (Duhoux 
et al., 2012). Results from this study suggest that interventions are needed to increase the extent 
to which primary mental health care confirms to evidence based practice recommendations 
(Duhoux et al., 2012). Such interventions should target specific populations, by enhancing 
accessibility to psychotherapy, family practitioners, and interventions that provide support to 
primary care practitioners in their clinical practice with patients undergoing treatment for 
depression (Duhoux et al., 2012). 
Saver and colleagues conducted a semi-structured qualitative study. They analyzed 15 
subjects who had been recruited from two primary care clinics and were currently undergoing 
treatment for major depression (Saver et al., 2007). The objective was to identify gaps and 
barriers that were amendable to interventions and that could improve depression care for future 
patients (Saver et al., 2007). The results from the study demonstrated that majority of the 
subjects, had recurrent depression, had reported barriers to obtaining information about 
depression, and its treatment options, including reports of multiple visits to primary care 
practitioners without the question of depression being raised (Saver et al., 2007). These findings 
suggest that quality improvement efforts should address not only screening and follow-up but 
patient education about depression and treatment options along with elicitation of treatment 
preferences (Saver et al., 2007). 
Reluctance to Prescribe Antidepressants in Primary Care. 
A meta‐analysis by Gilbody et al., of studies in which clinicians were randomly presented 
with the results of a depression screen also examined whether those patients subsequently 
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received interventions for depression (Gilbody, Sheldon, & Wessely, 2006). The notification had 
a borderline significant effect on increasing any intervention (RR = 1.30, 95% CI = 0.97–1.76), 
but the heterogeneity was large (I
2 
= 81%), with studies that randomized only high‐risk patients 
tending to show a larger effect size than those that randomized unselected patients (Gilbody, 
Sheldon, & Wessely, 2006). When the analysis focused on the prescription of antidepressants, 
there was no difference between the intervention and the control group (RR = 1.20, 95% CI = 
0.87–1.66). These findings suggest that when provided with the results of all positive depression 
screens, even on selected cases, clinicians might be minimally inclined to do something, but not 
necessarily to prescribe antidepressants (Gilbody, Sheldon, & Wessely, 2006). 
Effectiveness of Screenings. 
A study by O'Connor, Whitlock, Beil, and Gaynes (2009), found that among the subset of 
patients who were depressed, screened patients were more likely than unscreened patients to be 
in complete depression remission upon follow-up. These studies suggest that feedback of 
screening results alone is not effective in reducing depressive symptoms. Rather, feedback of 
screening results, together with interventions to treat depression, leads to remission of depression 
compared to non-treated patients. However, it is impossible to determine the impact of screening 
alone for these studies with successful depression interventions.  
Screening Tools in Primary Care Settings 
A systematic review conducted by Williams et al. (2009) failed to yield any data 
describing health outcomes among screened and unscreened populations, or any studies 
examining the harms of screening. Although the study had methodological limitations with 
regards to the use and accuracy of depression screening instruments among older adults. The 
U.S. Preventive Services Task Force (USPSTF) guidelines recommends screening for depression 
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in primary care settings, where providers are prepared to accurately diagnosis and provide 
effective treatment and follow-up (Maurer, 2012). 
Several screening instruments have therefore been developed as tools to guide early 
detection of depression and clinical decision making (Richardson et al., 2010). The most highly 
recommended tools that meet the DSM-IV criteria for major depression is the Geriatric 
Depression Scale (GDS), the Patient Health Questionnaire-2 (PHQ-2), the Cornell Scale for 
Depression in Dementia (CSDD), and the Patient Health Questionnaire-9 (PHQ-9) (Kroenke, 
Spitzer, & Williams, 2003; Spitzer et al., 1999). These screening tools can be easily 
administered, interpreted by a variety of providers, or have good predictive properties, and are 
specifically designed as depression screening and diagnostic instruments, to be used in clinical 
practice and research settings (Kroenke, Spitzer, & Williams, 1999, Richardson et al., 2010).  
Screening Implementation 
A systematic review of the literature conducted by Stanford (2015) found that many 
primary care providers struggle to implement a screening and diagnosis program for depression 
in primary care due to factors that serve as barriers to depression screening. To proactively 
address barriers to depression screening Ell (2006) identified the organizational strategies that 
may facilitate the implementation of a successful depression screening program to include 
multifaceted quality improvement disease management interventions that change the way 
depression care is delivered, such as: (1) implementation of routine depression screening; (2) 
systematic application of evidence-based practice guidelines; (3) use of clinical decision-making 
protocols and algorithms; (4) providing follow-up through remission and maintenance; and (5) 
enhancing the role of nurses or social workers as depression care managers, as well as integration 
between primary care and mental health specialists or service systems. 
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Importance of Screening, Treatment and Follow-up 
Schoenbaum et al. (2002) conducted an observational analysis using a sample of 938 
adult patients with depressive disorder. The objectives was to screen 27,332 consecutive patients 
in participating practices; and to evaluate the effects of evidenced-based depression treatment in 
primary care mainly on patients’ clinical health status, and employment outcomes in the first six 
months of follow-up. The principal findings from this study demonstrate that at six months, those 
patients with appropriate care/treatment compared to those without it, had lower rates of 
depressive disorder, better mental health-related quality of life, and higher rates of employment. 
These findings indicate that when appropriate evidence-based depression screening, treatment, 
and follow-up is provided to diverse group of patients in community-based primary care settings, 
there is substantial improvement in clinical outcomes, quality of life outcomes, and employment 
status. 
Summary 
In conclusion, this literature review provides substantial evidence that when screening for 
depression in the absence of other interventions, depression screening may not be effective 
(Luchin, 2010). As exemplified by these research studies, the use of treatment algorithms by 
general practitioners in patients with geriatric depression may be associated with adequate 
treatment at the primary care level (Duhoux et al., 2012). Additionally, by quantifying the 
number of patients with depression, these research studies suggest that the method used for 
identifying geriatric depression may have substantial impact on the relationship between major 
depression and the use of healthcare services (Druss, Rask, & Katon, 2008 & Sanchez et al., 
2016). Lastly, the findings from these research studies serve as a reminder that symptoms of 
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major depression and treatment for those disorders may have different and at times competing 
effects on the use of mental health services (Druss, Rask, & Katon, 2008).  
Theoretical Framework/Evidence Based Practice Model  
This quality improvement project incorporated Andersen’s Behavioral Model of Health 
Care Service Use, as a theoretical framework to explore factors related to mental health care 
service use among older adults with depression (Graham et al., 2017; Parker, et al., 2013; 
Duhoux et al., 2012). This conceptual model was used to identify individuals and contextual 
factors potentially associated with adequate treatment of depression for older adults (Babitsch, 
Gohl, & Lengerke, 2012).  
According to Park and Colleagues (2013), this model (Appendix A) suggests that there 
are three factors that affect health behavior, which include: (1) predisposing factors, including 
demographics, social characteristics, and individual beliefs, (2) needs factors, such as an 
individual’s self perceived need for treatment and a practitioner’s evaluation of the disease, (3) 
enabling factors, such as personal resources that facilitate or are a barrier to access, as well as the 
availability of health care services in the community. This conceptual model can be readily 
applied to the geriatric population, as it includes issues specific to the depressed older adult 
population or age group.  
In order to successfully implement this quality improvement model for depression, key 
stakeholders were required to understand the relevant organizational structure and processes of 
the primary care setting (Post et al, 2009). The application of the model to this DNP project 
involved focusing on discrete elements of care coordination, and mapping out what behaviors 
need to change (McDonald et al., 2007). Under the guidance of this theoretical framework, 
depression screening measurements were used, as an indirect marker for preventative service 
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utilization (Jahangir, Irazole, & Rubinstein, 2012). Furthermore, screening for depression would 
improve the practitioner’s ability to recognize depression, and thereby provide the impetus for 
more adequate treatment that would improve overall outcomes for patients suffering from 
geriatric depression.  
Implementation Plan 
The implementation plan for this QI project incorporated the six different steps as 
identified in the Model for Evidence-Based Practice Change (Larrabee, 2004; Ciliska et al., 
2011).  
The first step involved the identification of the problem and assessment of the need for 
change in practice, which incorporated stakeholders such as clinicians, patients and nurses. This 
assessment was performed prior to the implementation of the project, through statements by 
clinicians and patients regarding the need for effective depression screening (Stafford, 2015).  
The second step was planning an intervention and the desired outcome. The third step 
was to focus on finding the best and most current evidence. For step two and three the plan was 
to review the literature for successful depression screening programs at other organizations; 
review evidence that supports depression screening tools; review evidence supporting national 
recommendations regarding depression screening; and finally review the literature addressing 
barriers to depression screening (Stafford, 2015). 
The fourth step was the design of the practice implementation plan/change. The planning 
of the practice change consisted of three parts (Larrabee, 2004; Ciliska et al., 2011). The first 
part of the planned practice change was to evaluate the current depression screening rates at the 
primary care clinic. The second part of the practice change consisted of a provider educational 
session regarding current depression screening rates and the planned initiation of depression 
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screening within the clinic. The final component consisted of the actual implementation of the 
PHQ-2 screening tool within the clinic (Stafford, 2015; Mitchell et al., 2013; Fann et al, 2009). 
Step five included the evaluation of the pre-and-post tests scores and verbal feedback 
from providers to decide if the practice change would be adapted, adopted, or rejected. Finally, 
the last step was integration and maintenance of the practice change. This step was completed 
after the evaluation and recommendations regarding the practice change were made at the 
conclusion of this project (Larrabee, 2004; Ciliska et al., 2011; Stafford, 2015). 
Project Design and Methods 
The primary goal of this DNP quality improvement project was to increase depression 
screening rates, and the identification of persons with depression, in an outpatient primary care 
setting. This was accomplished by implementing the PHQ-2 screening tool to facilitate 
depression screening in geriatric patients. Since geriatric depression requires a clinical evaluation 
by a healthcare professional trained in evaluating both the diagnostic criteria symptoms and other 
medical problems associated with depression (Snowden et al., 2009). This goal was 
accomplished by training all key stakeholders to identify the possible symptoms of depression, 
thus improving detection and depression outcomes.   
The second goal was to increase the utilization of the screening tool from 2.0% to 50% 
within three months in the primary care setting. This was accomplished through the use of the 
PHQ-2 screening tool by ancillary medical staff, to aid the provider(s) in identifying geriatric 
patients with depression, especially when symptoms may be subtle, masked, or confounded by 
comorbidities (Roman & Callen, 2008). Additionally, a positive screening test may trigger a 
diagnostic interview by the primary care provider, using the standard diagnostic criteria 
(USPSTF, 2010). 
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The third goal was to introduce the depression screening process and monitoring 
protocol, by providing each patient, clinician, and ancillary medical staff, those depression 
educational materials designed by the DNP student. In addition to the handouts, an annotated list 
of all local mental health specialists, was developed and disseminated to the geriatric patients 
and their depression care managers, who were then responsible for following-up with the 
geriatric patients.  
The fourth goal was to improve depression screening practices, coordination, and 
continuity of care for older adults with depression, by quantifying the number of referrals 
generated from routine depression screening. This was done by (1) assessing the knowledge of 
depression screening, treatment, and related referrals using a pretest-posttest design before, 
immediately after, and one month post intervention; (2) identifying the process and system 
changes needed for implementing the PHQ-2 screening process; and (3) evaluating the 
effectiveness of the PHQ-2 questionnaire which was disseminated to screen for geriatric 
depression during a primary care visit. 
Table 1: 
Goals, Objectives, and Expected Outcomes  
Goals Objectives Expected Outcomes 
1) To increase depression 
screening rates and the 
identification of persons 
with depression in an 
outpatient primary care 
setting. 
 
 
(a) To implement the PHQ-2 
screening tool to facilitate 
depression screening in geriatric 
patients. 
 
(b) To survey trends in diagnosis, 
treatment and referral rates for 
depression before and after 
implementation of screening tool. 
 
(c) To train all key stakeholders to 
identify symptoms of depression, 
(a) 90% adherence to the 
screening process/guidelines 
by clinicians, nurses, and 
ancillary medical personnel. 
 
(b) 50% of geriatric patients 
who screen positive for 
depression will not continue 
to screen positive 8-weeks 
later.  
(c) 95% key stakeholders 
engagement/education/staff 
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thus improving detection and 
depression outcomes. 
assisted depression care and 
management support. 
 
2) To increase the 
utilization of the screening 
tool from 2.0% to 50% 
within three months in the 
primary care setting. 
 
 
 
(a) To increase the use of the PHQ-
2 screening tool by ancillary staff, 
to aid the provider(s) in identifying 
geriatric patients with depression. 
 
(b) A positive screening test will 
trigger a diagnostic interview by 
the primary care provider, using the 
standard diagnostic criteria. 
 
(c) To identify older adults at risk 
for depression, and direct them for 
appropriate mental health services. 
 
(a) At least 90% adherence 
to annual depression 
screening will increase 
recognition of depression. 
 
(b) At least 85% of geriatrics 
with a positive screening test 
will be given a mental health 
referral or prescribed an 
antidepressant. 
 
(c) Integration of mental 
health services into primary 
health care. 
 
3) To introduce the 
depression screening 
process and monitoring 
protocol to each patient and 
provider. 
 
 
 
 
(a) To provide each patient, 
clinician, and ancillary medical 
staff the depression educational 
materials designed by the DNP 
student to increase knowledge of 
depression. 
 
(b) To develop and disseminate an 
annotated list of all area mental 
health specialists, to the geriatric 
patients and their depression care 
managers. 
 
(a) Pre-and-post intervention 
scores will be used to assess 
knowledge of depression. 
 
 
 
 
(b) Maintain follow-up of all 
geriatrics patients newly 
identified as depressed to 
ensure they do not fall 
through the cracks. 
4) To improve depression 
screening practices by 
quantifying the number of 
referrals generated from 
depression screening 
(a) To assess the knowledge of 
depression screening, treatment, 
and referrals. 
 
(b) To identify process and system 
changes needed for implementing 
the PHQ-2 screening process in 
primary care. 
 
(c) To evaluate the effectiveness of 
the PHQ-2 questionnaire in 
detecting geriatric depression. 
(a) Performance metrics will 
be used to monitor the 
process and outcomes of 
screening including mental 
health integration/referral. 
 
(b) Depression screening 
application will be used to 
increase provider awareness 
and prevalence of depression 
in their own practice; and to 
improve the performance 
and care the clinic provides. 
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Project Site and Population 
This DNP project took place in a primary care practice which primarily serves patients in 
Westchester and Putnam counties in the state of New York, as well as Stamford, Connecticut. 
This premier medical practice is designated as a level three patient centered medical home, 
which is the highest recognition for a medical group. This practice provides a wide range of 
comprehensive primary and preventive services that are patient-centered and evidence-based. As 
a medical group, their mission is to deliver compassionate, community-based medical care of the 
highest quality.  
This medical group and its team of medical professionals provide services to an urban 
population, that is mostly Medicare or Medicaid insured, and 90% are non-Hispanic white. A 
majority of their older patient population lives independently within the community setting, or 
semi-independently with home supervision; while approximately 15% reside in assisted or long-
term care facilities (Abrams et al., 2015). Since many of these older patients have multiple co-
morbidities, the patients who met the diagnostic criteria for major depression, or who screened 
positive for depression using the PHQ-2 screening tool, were the target population for this 
quality improvement project. These participants were deemed eligible for inclusion, if they were 
65 years of age or older, able to speak and understand English, and able to provide informed 
consent. Exclusion criteria included patients who were non-English speaking; had sensory or 
cognitive impairment; and developmental delay severe enough that it precluded them from 
meaningful participation in screening for depression (Abrams et al., 2015). 
Organizational analysis of project site. As a full service, medical group, the primary 
care practice is immersed in an integrated health care system that includes primary care 
physicians and specialists. This extensive network of physicians and specialty practices include: 
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allergy/immunology, cardiology, dermatology, endocrinology, gastroenterology, neurology, 
ophthalmology, obstetrics/gynecology, pediatrics, plastic surgery, podiatry and urology. The 
interdisciplinary team consists of two physicians, nurse practitioners, nurses, certified medical 
assistants, and clerical staff. As a body of diversified care givers, the members of this team are 
specialty trained and dedicated to the care they provide. The team of medical providers is also 
multilingual, multicultural, and religiously diverse. This ensures that the medical staff can meet 
the many needs of their patients, who come from all corners of the globe.  
Evidence of stakeholder support. A stakeholder meeting to discuss the agenda of 
implementing the depression screening tool and to facilitate its integration into the primary care 
clinic was held. All stakeholders agreed to the long-term goal of integrating and coordinating the 
screening process, while sharing the responsibility of screening for depression. The depression 
care manager agreed to help shape the political dynamics associated with this change, by 
supporting the implementation process, and by getting the support of key stakeholders. By 
providing anchor and mentoring to those practitioners nervous about the implementation of the 
screening process, this would help stabilize the organization, and facilitate the successful 
implementation of the project. The depression care manager also did provide assurance to the 
medical team, about what was not going to change, what changes would occur in the screening 
process, and the need for the change.    
Measurement Instruments 
The most commonly used screening instrument in primary care settings is the patient 
health questionnaire-2 (Appendix C). This tool was used for this project, as it is the most viable 
and reliable screening instrument for depression among the elderly (Richardson et al., 2010). The 
tool has shown to have good diagnostic validity among large samples of geriatric patients, and 
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has the greatest sensitivity (100%) and specificity (77%) for screening for depression (Kroenke 
et al., 2003).  
The PHQ-2 is a time-saving tool that can be used in clinical practice as a first step in 
depression screening (Arroll et al., 2010; Richardson et al., 2010). The tool can be used to 
identify depressed patients who require further clinical evaluation using the PHQ-9 instrument 
(Richardson et al., 2010). Third, the tool is cost-effective for patients not previously identified as 
depressed, and can be incorporated into the electronic health record. Fourth, the tool can improve 
clinical outcomes in primary care settings, where mental health providers are lacking (Spitzer, 
Kroenke, & Williams, 1999; Luchins, 2010). The PHQ-2, which is an abbreviated version of the 
PHQ-9, can be a valuable tool, in assisting primary care physicians with screening for depression 
(Richardson et al., 2010; Arroll et al., 2010).  
The tool comprises the first two items of the PHQ-9 that evaluates the degree to which a 
patient has experienced depressed mood and anhedonia over the past 2-weeks (Kroenke et al., 
2010). The PHQ-2 items are rated on a 4-point scale, ranging from 0 (not at all) to 3 (nearly 
every day), for a total score ranging from zero to six (Kroenke et al., 2010). By using a cutoff of 
3 or greater, this tool has been found to have the greatest sensitivity and specificity for detecting 
major depression in older adult populations (Kroenke et al., 2003; Richardson et al., 2010). 
Data Collection Procedures 
This project lasted for a time period of 3-months, with data collection incorporated at 
multiple time points. The primary data was collected using the PHQ-2 assessment questionnaire, 
and completed by participants at three different time points throughout the intervention. Once 
potential participants had been identified, the medical assistant would inform them of the 
screening process, and obtain verbal and written consent. Upon consenting to the screening 
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process, eligible participants were invited into a private room to complete the assigned 
questionnaire. For those participants who could not read or write, they were assisted by the nurse 
and/or medical assistant, by reading out the questionnaire, and documenting the responses.  
Survey forms were pre-packaged into a sealed envelope; and the forms were distributed 
and collected between 1
st
 of October, 2017 till 31
st
 of December, 2017. For those items that were 
not answered or were incorrectly answered by the participants, such items were transcribed into 
the electronic health record (EHR) as missing data. The completed questionnaires were 
forwarded to the data entry clerk/nursing assistant, who would enter the data into the EHR (Al-
Qadhi, Rahman, Ferwana, & Abdulmajeed, 2014).  
Ethics and Human Subjects Protection  
The proposal was submitted to the University of Massachusetts Institutional Review 
Board (IRB) for approval. The project was initiated once the approval from the UMass IRB was 
received (Appendix F). All participants eligible to participate in the project were provided a 
written informed consent to participate in the project.  
Participants were explicitly informed in writing that they could withdraw their consent to 
participate, without specification of reasons, and with no negative consequences to their future 
medical treatment. Eligible participants included older adults over the age of 65. Data was 
obtained via weekly EHR audits. During the DNP project, all data collected was kept in a secure 
location to ensure privacy. To maintain confidentiality and anonymity, individual identifiers such 
as name, birth date, or social security numbers were not used in data collection. Upon conclusion 
of the project, all data collected was destroyed.  
Results 
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Over a six month period, four general practitioners and three care managers were trained, 
and two hundred and twelve participants were recruited.  
Sample   
In the pre-intervention phase, a total of ten staff members were invited to participate in 
the project including two physicians, two nurse practitioners, three nurses, two certified medical 
assistants, and a clerical staff. The mean age of participants was 48.6 years (SD=9.4 years). In 
terms of education, three had a doctoral level degree, one a master’s level degree, three a 
bachelor’s degree, two an associate’s degree, and one a certificate level degree. Providers and 
staff were given an information session in December 2017 and the project was completed in 
March 2018.  
The total number of patients included in the survey analysis was 212, with 119 females 
(56.1%) and 93 were males (45.9%). 
Table 2:  
Characteristics of the sample population (N=212) 
Sample Characteristics 
 
 
Age (years) Minimum Age 65   
Maximum Age 75   
Mean Age (SD) 48.6 (SD=9.4)   
Gender n (%) 
 
Female 56.1% (n=119)   
Male 45.9% (n=93)   
TOTAL  100% (n = 212   
Marital status Single 18% (n=38) Education  
Married  53.4% (n=113) High school grad 37% (n=17) 
Separated/Divorced  25% (n=53) Some college 73% (n=34) 
Widowed 3.6% (n=8) College + 85% (n=40) 
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TOTAL  100% (n=212   
Ethnicity Caucasian/White 57.5% (n=121) African American 9.9 % (n=21) 
Latino/Hispanic 30.6% (n=65) Asian/Mixed race 1.4% (n=3) 
 
Of those included 53.4% were married, and 47% were between 65-to-75 years. A 
hundred and twenty two patients (57.5%) were white, 65 (30.6%) were Latino, 21 (9.9 %) were 
black, and 3 (1.4%) were Asian/Mixed race. The percentage of the total sample that screened 
positive for depression was recorded in a chart (see Table 3). 
Table 3:  
The prevalence of depression among older patients screened for depression 
PHQ-2 Screening 
Category Scale  Minimal Mild Moderate Moderately 
Severe 
Severe Total 
# of patients 103 63.6 27 12 6.9 212 
% of patients 49 30 12.5 5.5 3.0 100 
Category Scale Absent Present PHQ-2 (0 
or higher) 
Referred to 
Mental Hlth 
Referred to 
Counseling 
Follow-up 
Appt. 
# of patients 103 109 46 18 27 64 
% of patients 49 51 21 8.9 12.5 30 
 
The screening was considered positive if the intake nursing note or encounter form was 
documented “screening positive” or “patient referred to provider” or “if affirmative responses to 
screening questions were noted.” 
In the intervention phase, a total of 250 questionnaires were distributed to those eligible 
to receive the PHQ-2 questionnaire. Twenty-five patients (10%) refused to participate, and17 
(6.8%) were excluded from participation primarily because they already had a diagnosis of 
affective disorder, cognitive impairment, or developmental delay in their medical records. Of the 
SCREENING FOR MAJOR DEPRESSION   26   2 
 
250 questionnaires completed, 15 (6%) incomplete questionnaires were rejected due to missing 
data. Over half of the patients (51.5%) included were exhibiting depressive symptoms on the 
basis of PHQ-2, of which 30% were mild, 12.5% moderate, 5.5% moderate-to-severe and 3.0% 
severe cases. For those patients’ ≥ 65 years of age, seen in the past six months with a PHQ-9 
screening tool, or had a negative PHQ-2 screening in the past year, were screened again. 
Forty six patients (21%), scored 0 or higher on the PHQ-2 questionnaire. Nineteen 
patients (8.9%) out of the 46 were referred to a mental health provider or prescribed an 
antidepressant. Eleven patients (5.1%) out of the 19 reported they were receiving treatment for 
depression. Twenty seven (12.5%) out of the 46 were referred for counseling. A total of sixty 
four patients (30%) were given recommendations to schedule a follow-up appointment for 
further clinical evaluation. Of those sixty four patients only three failed to return for follow-up 
appointments (see Table 3).  
At end of the 12-week time period, depression scores were significantly associated with 
female gender (p-value 0.039), and higher educational level (p-value 0.005).  
Table 4: 
Post-Intervention PHQ-2 score for depression in patients screened (N =119) 
                                      
                                                             Regression Analysis                                                                   
                                       R                        N (%)                 M(SD)                     P-value     
Female gender                                          119 (56.1)                                            0.039 
Age                                                                                      48.6(9.4)                   0.78 
Baseline PHQ-2             R1= 0.69                                                                         0.30 
Baseline PHQ-9             R2= 0.62                                                                         0.10 
Education Level                                                                                                    0.005 
Depression at baseline                              46 (21)              
Depression at 12-weeks                            19 (8.9)                                                             
Change, n (%)                                           27 (58.6) 
Depression at baseline          
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Regression analysis showed that PHQ-2 and 9 were strongly correlated R1= 0.69, and R2 = 0.62 
(see Table 4).  
The pretest and posttest on the depression screening initiative were analyzed using 
descriptive statistics for all pre-and-post test questions. A weekly audit to monitor the healthcare 
provider and staff usage of the PHQ-2 depression screening tool was done by the DNP student. 
The PHQ-2 scores were placed in the EHR, by the intake nurse and/or nursing assistant 
(Sanchez, Eghaneyan, & Trivedi, 2016). This included the dates of screening and rescreening 
PHQ-2 scores. To enable the provider to interpret the PHQ-2 scores, an electronic notification 
embedded within the EHR software, was used to inform the provider which participant screened 
positive for depression (Sanchez, Eghaneyan, & Trivedi, 2016).   
Cost-Benefits Analysis 
A cost analysis to estimate the direct and indirect costs of depression, including the cost 
savings of screening for depression was conducted (Al-Qadhi, Rahman, Ferwana, & 
Abdulmajeed, 2014). The estimated costs for this quality improvement project included data 
collection, measurement, and analysis, the comparison of local data with national benchmark 
data, and the costs for the educational program and implementation of the project as presented in 
Table 5.  
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Table 5:  
The cost of depression based on screening instrument PHQ-2 cut-off score ≥ 3 
 
Direct Cost Rating Basis Unit Cost 
(Dollars) 
Patients/100 Total Comments 
PHQ Screening 
 
Once/month 20 100 2,000  
PCP Visits 
 
3-visits/year 200 50 30,000  
Specialist Visits 
 
6-visits/year 400 20 48,000  
Medication 
 
One full year 300/month 50 180,000  
Hospitalization 
 
14 days/year 2,500/day 8 280,000  
Total    540,000  
      
Indirect Cost Rating Basis Unit Cost 
(Dollars) 
Patients/100 Total Comments 
Care-giver 
 
20 days/year 8,000/month 30 240,000  
Suicide Year 2016 450,000/life 2 900,000 
 
 
Total    1,140,000  
Grand Total    1,680,000  
      
  
Due to the availability of computer based documentation system, there was no capital 
investment required for this project. Also, given the overwhelming cost for depression treatment 
in the inpatient hospital setting, any new therapy that would allow patients to be treated in the 
outpatient setting/clinic could result in significant cost savings, especially for patients age 65 
years or older (Niederman, et al., 1998). Others have estimated savings of up to 520 dollars 
($165) per patient screened once a year (Al-Qadhi et al., 2014). 
Providers Pre and Post-test Scores 
The pre-and-post test surveys were used to evaluate the provider’s knowledge and 
confidence with administering the PHQ-2 screening instrument. This was accomplished by 
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administering a pre-and-post test questionnaire to all participating providers (Appendix D & E). 
Twelve pre-test surveys were distributed, but only four had responses. The results of the pre-and-
posttest data are summarized in Table 6 and 7.  
Table 6: 
Descriptive Statistics of Pre-test Scores 
 
 
 
 
N(#) 
 
Min. 
 
Max. 
 
Mean 
 
M(SD) 
How comfortable do you feel about using 
validated depression screening tools? 
 
 
2 
 
 
2 
 
 
4 
 
 
3.00 
 
1.414 
I have clinical experience in managing 
patients with major depression? 
 
 
4 
 
 
3 
 
 
4 
 
 
3.50 
 
0.707 
I am confident in my clinical experience in 
managing depression and have received 
formal training in mental health? 
 
 
4 
 
 
 
1 
 
 
 
3 
 
 
 
2.00 
 
 
1.414 
Is administration of depression screening 
tool by non-providers staff appropriate? 
 
 
4 
 
 
0 
 
 
5 
 
2.50 
 
3.535 
How often do you currently use a depression 
screening tool with patients? 
 
 
3 
 
 
2 
 
4 
 
3.00 
 
 
1.414 
Is the use of a depression screening tool in 
the primary care useful? 
 
 
4 
 
 
4 
 
5 
 
4.50 
 
0.707 
Depression is a serious medical condition 
that requires treatment?  
 
 
4 
 
 
4 
 
5 
 
4.50 
 
0.707 
Stigma is a major barrier to people accessing 
treatment for depression? 
 
4 
 
4 
 
5 
 
4.50 
 
0.707 
 
The pre-test survey revealed that all four providers (100%) had limited formal training 
with mental health treatment. The lowest pre-test score was one (strongly disagree) and the 
highest score was three (neutral). Three of the four providers (75%) stated that they only used a 
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depression screening tool less than (30%) of the time, with one of the provider’s (25%) stating 
they used depression screening tools ninety-percent of the time. The lowest pre-test score was 
two (disagree) and the highest score was four (agree). Two of the four providers (50%) stated 
low comfort with depression screening tools. The lowest pre-test score was two (disagree) and 
the highest score was four (agree). One provider rated his comfort with depression screening 
tools at five (strongly agree) on the Likert scale.  
All four providers (100%) stated they were comfortable with a depression screening 
instrument being administered by a non-provider medical staff, and the highest score was five 
(strongly agree). Providers also agreed that a depression-screening tool was useful in primary 
care; with all four providers stating depression screening could be useful 90% of the time. The 
lowest score was four (agree) and highest score was five (strongly agree).  
In terms of having clinical experience in managing patients with major depression, the 
lowest score was three (neutral) and the highest score was four (agree). All four providers agreed 
that depression was a serious medical condition that requires treatment, and that stigma is a 
major barrier to patients accessing treatment for depression. The lowest score was four (agree) 
and the highest was five (strongly agree) on the Likert scale. 
The post-test surveys were distributed, and eight responses were received. Four of eight 
providers (50%) stated they only used the PHQ-2 fifty-five percent of the time, with three 
providers (37%) reporting use of the PHQ-2 ninety-five percent of the time. Thus rating their use 
of the instrument as four (agree) on lowest score, and five (strongly agree) as the highest score. 
Although there was only a (17%) increase, two of three providers stated they were using the 
PHQ-2 more frequently compared with pre-test results. 
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After implementation, six of the eight providers (75%) rated their comfort with 
depression screening tools as five (strongly agree), with the other two providers (25%) rating 
their comfort as four (agree) on the Likert scale. By evaluating all eight provider responses, it is 
evident there was improved comfort with the screening tool, with all provider responses rating a 
four or five on the Likert scale. This overall increase in comfort demonstrates the positive effect 
that an education session and structured implementation plan can have on primary care 
providers. 
Table 7: 
Descriptive Statistics of Post-test Scores 
 
 
 
 
N(#) 
 
Min. 
 
Max. 
 
Mean 
 
M(SD) 
How comfortable do you feel about using 
validated depression screening tools? 
 
 
6 
 
 
4 
 
 
5 
 
 
4.50 
 
0.707 
I have clinical experience in managing 
patients with major depression? 
 
 
7 
 
 
4 
 
 
5 
 
 
4.50 
 
0.707 
I am confident in my clinical experience in 
managing depression and have received 
formal training in mental health? 
 
 
7 
 
 
 
4 
 
 
 
5 
 
 
 
4.50 
 
 
0.707 
Is administration of depression screening 
tool by non-providers staff appropriate? 
 
 
8 
 
 
4 
 
 
5 
 
4.50 
 
0.707 
How often do you currently use a depression 
screening tool with patients? 
 
 
4 
 
 
4 
 
5 
 
4.50 
 
 
0.707 
Is the use of a depression screening tool in 
the primary care useful? 
 
 
8 
 
 
4 
 
5 
 
4.50 
 
0.707 
Depression is a serious medical condition 
that requires treatment?  
 
 
8 
 
 
4 
 
5 
 
4.50 
 
0.707 
Stigma is a major barrier to people accessing 
treatment for depression? 
 
8 
 
4 
 
5 
 
4.50 
 
0.707 
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In summarizing, the pre-and-posttest data showed: (1) an increase in depression 
screening; (2) an increase in use of depression screening instruments; and (3) an increase in 
knowledge base after protocol implementation. Posttest data showed that (93%) of providers 
reported that they formally screened all patients compared to only (1%) stating they screened 
them pre-protocol. Pre-test data showed that (75%) of providers used a screening instrument 0 
out of 10 encounters compared to posttest data which showed that (93%) used a screening 
instrument at least 8 out of 10 encounters. There was also a (78%) increase in knowledge base 
about depression screening among the providers post implementation of the screening protocol. 
Discussion 
Overall, the intervention was effective in increasing the rates of depression screening at 
the primary care setting.  Initially, when presented to the providers during the educational 
session, the results of the initial retrospective chart review did not surprise the providers at the 
primary care clinic. Although previous reviews had been performed with similar results, using 
this knowledge and the Model for Evidence-Based Practice Change efforts were made to assist 
the medical clinic in making a sustainable change.  
Provider-related barriers. Similar to the barriers listed in the literature review, in the 
survey providers listed limited time for depression screening as the primary barrier, while a 
second barrier listed was the lack of a readily available screening tool. Although the three 
practitioners may have agreed that the appointment time allocated to each patient was enough to 
assess and treat the patient’s presenting complaints. Two of these practitioners expressed their 
disagreement that they did not have extra time to administer nor interpret the depression 
screening instrument. Additionally, one of these practitioners identified the lack of a screening 
tool as a barrier to depression screening; while two practitioners indicated that they were 
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unaware of any “depression screening template” that may be embedded in the electronic health 
records.      
Patient-related barriers. In addition to depression screening obstacles that are related to 
primary care practice, providers were able to identify patient-related barriers to implementation 
of a successful depression screening program to include: (1) the patient’s perception of bias and 
cultural competence in health care, (2) family perceptions of care, (3) practical barriers such as 
cost and transportation to therapy, and (4) lack of educational support and ease of access to 
mental health specialists that may impede the receipt of care (Ell, 2006).  
System-related barriers. Additionally, the identified system barriers included (1) lack of 
coordination and collaboration between providers in primary care; (2) inadequate continuity of 
care, and (3) shortage of nursing and social service professionals who have training and expertise 
in geriatric mental health (Ell, 2006). For these reasons, vulnerable patients may be unwilling or 
unable to utilize depression screening and risk assessment services, even if mental health 
services/specialists are available in the primary care setting.  
Suggestions for Improvement. The key lesson for this health care organization is that 
providers must be vigilant in recognizing the complexities of detecting and managing depression, 
and attempt to reduce the barriers to good quality care. Thus, it is incumbent upon providers to 
organize their practices so as not to overlook the mental health problems of these vulnerable 
patients. It might be prudent to implement routine screening and assessment programs that will 
aid providers who may otherwise overlook the emotional distress of these vulnerable patients. 
Subsequently, if clinicians are educated about the symptoms of depression, providers will be 
well positioned to look for these symptoms, and thereby improve the accurate assessment and 
screening of depression in their older-adult population (Mitchell, Vahabzadeh, & Magruder, 
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2011). Therefore, this quality improvement project attempted to assist the primary care 
provider(s) in overcoming these barriers. 
Strengths and Limitations 
Although there were benefits to depression screening, there were several limitations to 
the approach that focused on depression alone. Clinicians within the primary care clinic have 
recognized the need to identify multiple mental health conditions including but not limited to 
depression (Mitchell, Vahabzadeh, & Magruder, 2011). However, only a handful of these 
clinicians are now beginning a new phase of screening in which outcomes such as emotional 
distress, unmet psychosocial needs, functional limitations, and the desire for help are the key to 
depression (Mitchell, Vahabzadeh, & Magruder, 2011).  
Implications for Practice 
The results from this quality improvement project demonstrate that stakeholders can 
work together with patients to identify and monitor depression screening within the primary care 
setting. Second, the results demonstrate that the use of PHQ-2 or a similar depression-screening 
tool can be an effective means of depression screening in a more diverse population. Thirdly, the 
findings have the potential to lead to the integration of a depression screening program in the 
primary care setting. Lastly, the findings provide valuable information about models of 
depression care that can be implemented and evaluated in a clinical setting (Palmer et al., 2015).     
It has been further demonstrated that there is an accumulated knowledge base regarding 
the potential effectiveness of the integration of mental health services into primary care (Lake, & 
Turner, 2017). However, the remaining challenge is to find effective and efficient strategies not 
only to disseminate, but also to support the uptake, implementation, and sustainability of these 
interventions in the care of older adults with depression. By utilizing Andersen’s Behavioral 
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Model of Healthcare Service Use (Anderson, 2008); the theoretical framework was used to 
determine which individual variables serve as barriers toward health care use (Fleury, Grenier, & 
Bamvita, 2015). This project built upon the model to assess the relationships and predictability 
between individual variables and behavioral health care utilization within an integrated health 
care model (Anderson, 2008; Lindsay Nour et al., 2009).  
In applying Andersen’s behavioral model of health care use and the model for evidence-
based practice change. The models were used to optimize primary care, thus allowing 
individual’s to receive better depression care, as well as to assist the primary care clinic, in 
merging towards an integrated behavioral health care model (Lindsay Nour et al., 2009). Given 
the rates of depression among older adults are rising, and are considered to be a significant 
public health problem. The purpose of this quality improvement project was to focus on three 
approaches to this problem: (1) the integration of a depression screening program within the 
primary care clinic; (2) the integration of depression screening into routine assessment of older 
adults; and (3) the integration of evidence-based interventions for depression by primary care 
providers, depression care managers, or by licensed mental health specialists/professionals, in 
partnership with the primary care clinic.  
The design and implementation of a depression screening algorithm into the project, led 
to the integration of a depression screening program that will continue to be used in the primary 
care clinic, to improve the outcomes of patients with depression. It will also lead to an increase 
in the number of older adults screened for depression who will seek primary/mental health 
services. Lastly, it will lead to a decrease in the incidence of suicide among older adults, and 
reduce the health disparity of depression among this population.  
SCREENING FOR MAJOR DEPRESSION   36   2 
 
In addition, since the chosen self-assessment questionnaire (PHQ-2) can dramatically 
improve depression detection rates. The primary care clinic was encouraged by the high rate of 
depression screening as achieved, suggesting that screening for depression is a feasible goal. 
Thus, providers will pursue implementation of routine depression screening using the chosen self 
assessment questionnaire.  
Further work may be needed to evaluate the provider’s perception of the screening tool 
and to identify why such tools are not being used on routine assessment of older adults. Further 
evaluation is also needed to explore situations in which the patient was screened positive for 
depression but was never referred to the appropriate mental health provider. Such tracking could 
include patient samples among several different primary care clinics, using different depression-
screening tools, and confirmation of screened patients with the gold standard for measuring 
depression, such as the DSM-IV criteria (Ceccarini, Manzoni, & Castelnuovo, 2014, Gelaye et 
al., 2014).  
This project analyzed whether the success of depression treatment relies on variables 
such as early detection, social support, type of medical illness, and other mitigating factors. 
Regardless of the screening tool or method used, the early detection of depression must be 
tailored to interventions, and treatments that are central to ensuring that all patients receive 
adequate intervention/treatment from depression. 
Conclusion 
The findings from this DNP Project demonstrate at least two factors that may be 
considered in an effort to improve primary care in older persons with depression. First, the 
successful treatment of depression may have the potential to mitigate not only the burden of this 
illness, but also depression’s adverse effects on access to, and the comprehensiveness of medical 
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services provided (Druss, Rask, & Katon, 2008). Second, specialty mental health treatment may 
also be associated with difficulties in coordination and continuity of medical care. Therefore, 
models that target treating depression in primary care may have the potential to improve 
depressive symptoms while not jeopardizing, and perhaps improving, quality of medical care, 
and it cost (Druss, Rask, & Katon, 2008). 
This project supports the following:  
1) There is a need for depression screening in older adult patients in the primary care;  
2) Primary care providers should be trained and made aware of the benefits of screening for 
major depression and appropriately refer patients for mental health follow up; 
3) Patients should receive education about depression in order to understand the perils of 
untreated depression, and the benefits of depression treatment so as to achieve better quality 
of life. Overall, this evidence-based quality improvement project proves the merits and 
importance of screening for depression at the primary care level. 
Finally, there is a paucity of data despite the recommendations made by the World Health 
Organization (WHO), the American Academy of Family Physicians (AAFP), and the U.S. 
Preventive Services Task Force (USPSTF), that support screening adults for depression in 
primary care practices that have systems in place to accurately diagnose, effectively treat, and 
provide follow-up (WHO, 2013; AAFP, 2012; & USPSTF, 2015). Such systems, although in 
place for some time, have failed to demonstrate improvements in the health status of older adults 
seen in primary care clinics (Saver et al., 2007). 
Several of the potential barriers identified to implementing a screening tool within the 
primary care clinic include: (1) concerns about stigmatizing the patient with a psychiatric 
diagnosis; (2) time pressure/limited appointment time to screen for depression; (3) productivity 
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pressures to detect, screen and manage depression; (4) inadequate knowledge about diagnostics 
criteria; (5) the cost of screening or treatment options; (6) limited resources to screen for 
depression within the office; (7) lack of systematic approaches to detecting and managing 
depression; (8) limited community resources/mental health coverage to treat and follow-up on 
positive screens; and (9) potential limited knowledge regarding screening recommendations and 
screening tools (Ell, 2006; Park & Unὓtzer, 2012; Stafford, 2015).   
In conclusion, although there is direct evidence of the isolated health benefits of 
depression screening in primary care clinics. The totality of the evidence supports the benefits of 
screening older adult populations, particularly in the presence of additional treatment supports, 
such as care management, treatment protocols, and availability of specialty trained depression 
care providers (O’Connor et al., 2016). The indirect evidence shows that depression screening 
instruments can identify adults, including older adults, who need further evaluation and may 
need treatment for depression, and that depression treatment is likely to be effective (O’Connor 
et al., 2016). 
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Appendix A 
 Sample Diagram of the Andersen Behavioral Model 
 
Appendix B 
 Sample Diagram on Behavioral Model of Late Life Depression 
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Appendix C 
The PHQ-2 Screening Tool  
 
The Patients Heath Questionnaire-2 (Short Form) 
 
 
Site Name: ----------------            Patient’s Name: ---------------               Date of Visit: --------------- 
 
Initials of Interviewer: ----------------          Date of Screening: ---------------            
 
 
 
During the past 2-weeks, how often have 
you been bothered by any of the 
following problems?  
 
 
Not At 
All 
 
 
Several 
Days 
 
 
More Than  
Half The 
Days 
 
 
Nearly 
Every Day 
 
1) Little interest or pleasure in doing 
things? 
 
 
0 
 
1 
 
2 
 
3 
 
2) Feeing down, depressed or hopeless? 
 
 
0 
 
1 
 
2 
 
3 
  
  
Total Score: --------------- 
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Appendix D 
Pretest Questionnaire/Survey 
Please indicate how strongly you agree or disagree with the following statements. If unsure, 
please provide your best guess. 
 
 
SURVEY QUESTIONS 
 
Strongly 
agree 
Agree Somewhat 
agree 
Disagree Strongly 
disagrees 
1. How comfortable do you feel about 
using validated depression 
screening tools? 
 
2. I have clinical experience in 
managing patients with major 
depression? 
 
3. I am confident in my clinical 
experience in managing depression 
and have received formal training 
in mental health? 
 
4. Is administration of depression 
screening tool by non-providers 
staff (such as MA) appropriate? 
 
5. How often do you currently use a 
depression screening tool with 
patients? 
 
6. Is the use of a depression screening 
tool in the primary care useful? 
 
7. Depression is a serious medical 
condition that requires treatment? 
 
8. Stigma is a major barrier to people 
accessing treatment for depression? 
 
 
5 
 
4 
 
3 
 
2 
 
1 
  
5 
 
4 
 
3 
 
2 
 
1 
 
 
 
5 
 
 
4 
 
 
3 
 
 
2 
 
 
1 
 
5 
 
 
4 
 
3 
 
2 
 
1 
 
 
5 
 
 
4 
 
 
3 
 
 
2 
 
 
1 
 
5 
 
4 
 
3 
 
2 
 
1 
 
5 
 
 
4 
 
3 
 
2 
 
1 
 
 
5 
 
 
 
4 
 
3 
 
2 
 
1 
Please note: by returning this questionnaire, you are giving your consent to participate. 
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Appendix E 
Post-test Survey (12 weeks post-intervention) 
 
1. The provider handout was helpful?                                          Yes                     No 
2. The depression screening handout was helpful?                      Yes                     No 
3. Did the implementation of a depression screening tool help?  Yes                     No 
 
 
SURVEY QUESTIONS 
 
Strongly 
agree 
Agree Somewhat 
agree 
Disagree Strongly 
disagree 
1. How comfortable do you feel about 
using validated depression 
screening tools? 
 
2. I have clinical experience in 
managing patients with major 
depression? 
 
3. I am confident in my clinical 
experience in managing depression 
and have received formal training 
in mental health? 
 
4. Is administration of depression 
screening tool by non-providers 
staff (such as MA) appropriate? 
 
5. How often do you currently use a 
depression screening tool with 
patients? 
 
6. Is the use of a depression screening 
tool in the primary care useful? 
 
7. Depression is a serious medical 
condition that requires treatment?  
 
8. Stigma is a major barrier to people 
accessing treatment for depression? 
 
 
5 
 
4 
 
3 
 
2 
 
1 
  
5 
 
4 
 
3 
 
2 
 
1 
 
 
 
5 
 
 
4 
 
 
3 
 
 
2 
 
 
1 
 
5 
 
 
4 
 
3 
 
2 
 
1 
 
 
5 
 
 
4 
 
 
3 
 
 
2 
 
 
1 
 
5 
 
4 
 
3 
 
2 
 
1 
 
5 
 
 
4 
 
3 
 
2 
 
1 
 
 
5 
 
 
 
4 
 
3 
 
2 
 
1 
Thank you for taking the time to fill out this questionnaire. Your participation and feedback is highly appreciated 
and will help to determine how best to implement depression screening into primary care practice. 
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Appendix F 
Barriers to Depression Screening 
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Appendix G 
USPSTF Analytic Framework for Depression 
 
